A Los Angeles influencer recently went viral for filming herself waiting for a first date at a restaurant — only for the man ...

George Bennett hunched himself over his handlebars repeatedly beyond the finish line of Il Lombardia. He looked shell-shocked. It was mostly to get his breath back after six hours of lung-busting ...

There’s a common belief that Windows has more apps — and better ones, too — than Linux. And sure, that’s true in a few ...

As data center projects accelerate across North America, NOARK combines global engineering, diversified supply, North American compliance expertise, and localized assembly and service to address ...

As convenient tools become more abundant, perhaps we have started trying to build things just because we can, before even ...

ASX healthcare is continuing its recovery after defying a historically softer September to be the top performing sector for ...

ONLYOFFICE presents the major autumn update 10.0 with context-aware AI tools directly in the editors, new modular Apps, and a ...

Security starts with the hardware. OneKey Pro 2 features four EAL6+ secure elements — the only hardware wallet on the market ...

South 8’s AE35 cell enters the soldier power market in Galvion’s new SoloPack Arctic ...

PWCM not subject to TVA new tariffs of approximately $1.5 million per megawatt for new and expanded data center load above ...

The Court dismissed the petition filed under Section 528 BNSS by an accused challenging the trial court orders that refused to reopen defence evidence in a Section 138 NI Act case.

SZN-8141 is a bifunctional Wnt agonist and vascular endothelial growth factor (VEGF) antagonist antibody being developed as an intravitreal injection for the treatment of diabetic macular edema (DME).